INSULIFT™ Vildagliptin (50mg)
A Novel Anti-Hyperglycemic Agent
- A new class of drugs for type-2 diabetes.
- Optimum Glycemic Control: Better control of FPG levels Significant control in HbA1c by 3.4%
- Enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion.
- Enhances the sensitivity of alpha cells to glucose, resulting in more glucose-appropriate glucagon secretion.
- The enhanced increase in insulin/glucagon ration during hyperglycemia results in a decrease in fasting & post-prandial hepatic glucose production, leading to reduce glycemia.
